Increased lipophilicity and subsequent cell partitioning decrease passive transcellular diffusion of novel, highly lipophilic antioxidants.
暂无分享,去创建一个
Thomas J. Raub | M. E. Houghton | N. Ho | G. Sawada | N F Ho | C L Barsuhn | M E Houghton | B S Lutzke | T J Raub | G A Sawada | G E Padbury | C. Barsuhn | B. Lutzke | G. Padbury
[1] D. D. Perrin,et al. pKa prediction for organic acids and bases , 1981 .
[2] E. Doelker,et al. Intestinal absorption kinetics of various model drugs in relation to partition coefficients , 1988 .
[3] N. Greig. Drug Delivery to the Brain by Blood-Brain Barrier Circumvention and Drug Modification , 1989 .
[4] G. Sawada,et al. Novel, highly lipophilic antioxidants readily diffuse across the blood-brain barrier and access intracellular sites. , 1999, The Journal of pharmacology and experimental therapeutics.
[5] G. Lees. Contributory mechanisms in the causation of neurodegenerative disorders , 1993, Neuroscience.
[6] Y. Magata,et al. Evaluation of N-alkyl derivatives of radioiodinated spiperone as radioligands for in vivo dopamine D2 receptor studies: effects of lipophilicity and receptor affinity on the in vivo biodistribution. , 1992, Chemical & pharmaceutical bulletin.
[7] E. Hall,et al. Neuroprotective effects of the novel brain‐penetrating pyrrolopyrimidine antioxidants U‐101033E and U‐104067F against post‐ischemic degeneration of nigrostriatal neurons , 1997, Journal of neuroscience research.
[8] F. Sörgel,et al. Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges , 1994, Journal of the Neurological Sciences.
[9] J. Goodwin,et al. In vitro permeability of peptidomimetic drugs : the role of polarized efflux pathways as additional barriers to absorption , 1997 .
[10] S. Yalkowsky,et al. A Physical Chemical Basis for the Design of Orally Active Prodrugs , 1980 .
[11] R. Guy,et al. An evaluation of structure-penetration relationships in percutaneous absorption. , 1992, Farmaco.
[12] E. Hall,et al. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. , 1994, Advances in pharmacology.
[13] C. Hansch,et al. Lipophilic character and biological activity of drugs. II. The parabolic case. , 1973, Journal of pharmaceutical sciences.
[14] R. Conradi,et al. The relationship between peptide structure and transport across epithelial cell monolayers , 1992 .
[15] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[16] C. Bernards,et al. Physical and chemical properties of drug molecules governing their diffusion through the spinal meninges. , 1992, Anesthesiology.
[17] D. Scherman,et al. High lipophilicity decreases drug transport across intestinal epithelial cells. , 1994, The Journal of pharmacology and experimental therapeutics.
[18] M. Kansy,et al. Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).
[19] E. Hall,et al. Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. , 1995, Journal of medicinal chemistry.
[20] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.
[21] E. Hall,et al. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models. , 1997, The Journal of pharmacology and experimental therapeutics.
[22] Thomas J. Raub,et al. Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. , 1993, Journal of drug targeting.